<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Analyst initiations: EFII, FNDT and VIAP]]></title><link>http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/</guid><comments>http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/analyst-initiations/" rel="tag">Analyst Initiations</a></p><strong><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/11/fly-logo-(aol).gif" /></a>MOST NOTEWORTHY:</strong> Electronics for Imaging, Fundtech and VIA Pharmaceuticals were today's noteworthy initiations:<br />
<ul>
    <li>Banc of America initiated <a href="http://finance.aol.com/quotes/electronics-for-imaging-inc/efii/nas">Electronics for Imaging</a> (NASDAQ: <a href="http://finance.aol.com/quotes/electronics-for-imaging-inc/efii/nas">EFII</a>) with a Buy rating and $26.50 target, as it sees leverage potential in 2008 from cost reductions and revenue mix and believes stronger controller revenue mix and ink from inkjets could help gross margin in 2H08. <br /></li>
    <li>JMP Securities expects <a href="http://finance.aol.com/quotes/fundtech-ltd/fndt/nas">Fundtech</a> (NASDAQ: <a href="http://finance.aol.com/quotes/fundtech-ltd/fndt/nas">FNDT</a>) to benefit from an upgrade cycle among large banks to improve their payment systems, starting shares off with a Market Outperform rating and $19 target. <br /></li>
    <li>Rodman &amp; Renshaw resumed coverage of <a href="http://finance.aol.com/quotes/via-pharmaceuticals-inc/viap/nas">VIA Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/via-pharmaceuticals-inc/viap/nas">VIAP</a>) with an Outperform rating and $4 target. The firm expects VIAP's VIA-2291, a treatment for Antherosclerosis, Ph II data expected in mid-2008 to drive shares.</li>
</ul>
<strong>OTHER INITIATIONS:</strong><br />
<ul>
    <li>Oppenheimer initiated <a href="http://finance.aol.com/quotes/ardea-biosciences-inc/rdea/nas">Ardea Biosciences</a> (NASDAQ: <a href="http://finance.aol.com/quotes/ardea-biosciences-inc/rdea/nas">RDEA</a>) with a Buy rating and $15 target. <br /></li>
    <li><a href="http://finance.aol.com/quotes/sap-aktiengesellschaft/sap/nys">SAP AG</a> (NASDAQ: <a href="http://finance.aol.com/quotes/sap-aktiengesellschaft/sap/nys">SAP</a>) was initiated with an Equal Weight rating at Lehman. <br /></li>
    <li>CIBC resumed coverage of <a href="http://finance.aol.com/quotes/limelight-networks-inc/llnw/nas">Limelight Networks</a> (NASDAQ: <a href="http://finance.aol.com/quotes/limelight-networks-inc/llnw/nas">LLNW</a>) with a Sector Outperformer rating.</li>
</ul><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/">Analyst initiations: EFII, FNDT and VIAP</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 27 Nov 2007 11:01:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1048960/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/11/27/analyst-initiations-efii-fndt-and-viap/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Analyst Initiations</category><category>AnalystInitiations</category><category>Ardea Biosciences</category><category>ArdeaBiosciences</category><category>EFII</category><category>Electronics for Imaging</category><category>ElectronicsForImaging</category><category>FNDT</category><category>Fundtech</category><category>Limelight Networks</category><category>LimelightNetworks</category><category>LLNW</category><category>RDEA</category><category>SAP</category><category>SAP AG</category><category>SapAg</category><category>VIA Pharmaceuticals</category><category>VIAP</category><category>ViaPharmaceuticals</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Tue, 27 Nov 2007 11:01:00 EST</pubDate></item></channel></rss>
